The Global Remicade Biosimilars Market Driven By Growing Demand For Cost Effective Biologics
by Remicade, also known as infliximab, is a chimeric monoclonal antibody drug used to treat a variety of autoimmune diseases including rheumatoid arthritis, Crohn’s disease, ulcerative …